The FMS-like receptor tyrosine kinase 3 (FLT3) plays an natural part in managing the differentiation and proliferation of hematopoietic cells. Somaticmutations from the FLT3 have already been frequently identified in acute myeloid leukemia. Mutations in FLT3 primarily include internal tandem duplications (ITD) in the juxtamembrane domain, affecting 15%to 34%AML patients, or pointmutations in the tyrosine kinase domain in 8% to 12%of patients. Thesemutations are associatedwith an awful p...